Literature DB >> 19922253

Indigenous drugs in ischemic heart disease in patients with diabetes.

Shridhar Dwivedi1, Amitesh Aggarwal.   

Abstract

BACKGROUND: India is currently facing the silent epidemic of ischemic heart disease, type 2 diabetes mellitus (T2DM), hypertension, and stroke. Both diabetes and ischemic heart disease appear in Indian people a decade earlier compared to whites. The recent evidence that certain medicinal plants possess hypoglycemic, lipid-lowering, and immunomodulating properties on account of their rich flavonoid and/or other glucose-lowering active constituents merits scientific scrutiny in this regard.
OBJECTIVES: The present communication aims to give a brief review of those plants that could be useful in T2DM associated with hypertension, ischemic heart disease, and/or dyslipidemia.
METHODS: Aegle marmelos (bael), Allium sativum (garlic), Curcuma domestica (turmeric), Eugenia jambolana (jamun), Murraya koenigii (curry leaves), Trigonella foenum graecum (fenugreek), and Terminalia arjuna (arjun) have been found to be useful in diabetes associated with ischemic heart disease. Their active biomolecules have been identified. They have also been demonstrated to be safe in long-term use.
CONCLUSIONS: Further clinical research regarding their potency and efficacy vis-à-vis oral hypoglycemics needs to done.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922253     DOI: 10.1089/acm.2009.0187

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  2 in total

1.  Aged (Black) versus Raw Garlic against Ischemia/Reperfusion-Induced Cardiac Complications.

Authors:  Attila Czompa; Kitti Szoke; Jozsef Prokisch; Alexandra Gyongyosi; Istvan Bak; Gyorgy Balla; Arpad Tosaki; Istvan Lekli
Journal:  Int J Mol Sci       Date:  2018-03-28       Impact factor: 5.923

2.  Fenugreek extract as an inducer of cellular death via autophagy in human T lymphoma Jurkat cells.

Authors:  Nasser M Al-Daghri; Majed S Alokail; Khalid M Alkharfy; Abdul Khader Mohammed; Sherif H Abd-Alrahman; Sobhy M Yakout; Osama E Amer; Soundararajan Krishnaswamy
Journal:  BMC Complement Altern Med       Date:  2012-10-30       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.